- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03816384
Effect of Active Drain Line Clearance on Catheter-Associated Bacteriuria (CAB)
Effect of Active Drain Line Clearance With or Without Silver on Catheter-Associated Bacteriuria (The CAB Study)
Catheter-associated urinary tract infections (CAUTI) are the most common nosocomial infections in critically ill patients and are responsible for high morbidity rates, increased hospital stays and associated costs.
The purpose of this study is to evaluate whether active drain line clearance by the Accuryn Monitoring System reduces the incidence of CAUTI in hospitalized patients requiring catheters.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Urinary tract infection (UTI) is the most common healthcare associated infection (HAI) acquired in hospitals and is estimated to account for approximately 13% of hospital infections in the United States, of which 75% are associated with indwelling urinary catheters. It is estimated that between 12-16% adult inpatients will receive an indwelling urinary catheter during their hospital stay. The rate of catheter-associated UTI (CAUTI) are highest in burn ICUs, followed by inpatient medical wards and neurosurgical ICUs.
The purpose of this study is to evaluate whether active drain line clearance by the Accuryn Monitoring System reduces the incidence of bacteriuria and/or CAUTI in patients requiring catheters for more than 72 hours. This study will also evaluate the efficacy in reducing bacteriuria of the Accuryn silver fabricated silicone catheters.
Studietype
Fase
- Ikke aktuelt
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Adult (age ≥ 18)
- Patient or Legally Authorized Representative (LAR) possess the capacity to provide informed consent
- Indication for a urinary bladder catheter (or one currently in place)
- Expected urinary catheter requirement ≥ 72 hours
- No current urinary tract infection
- No current indication for prophylactic antibiotics. If a surgical patient, receive perioperative antibiotics for no greater than 24 hours
Exclusion Criteria:
- Inability to receive a urinary bladder catheter
- Chronic suprapubic catheter in place
- Expected survival < 72 hours
- Receipt of systemic antibiotics within 48 hours of enrollment, other than prophylactic antibiotics given at the time of surgery
- Surgery of the genitourinary tract in the past 6 months prior to admission
- Deemed unfit for the protocol by the investigator for any reason
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Aktiv komparator: Standard of Care
Patients will receive Standard of Care, commercially available catheter utilized by hospital system.
|
Standard of care urinary drainage system.
|
Eksperimentell: Drain Line Clearance (DLC) Group
Patients will receive FDA-approved Accuryn Monitoring System with active drain line clearance and plain silicone catheter.
|
Urinary drainage system with active drain line clearance and plain silicone catheter.
|
Eksperimentell: Drain Line Clearance and Silver (DLCS) Group
Patients will receive FDA-approved Accuryn Monitoring System with active drain line clearance and silver-doped silicone catheter.
|
Urinary drainage system with active drain line clearance and silver-doped silicone catheter.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Difference in percentage of catheter-associated bacteriuria
Tidsramme: 30 days
|
To study the difference in rate of catheter-associated bacteriuria between SOC catheters and Accuryn silicone or Accuryn silver-doped catheters with active drain line clearance.
|
30 days
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Percentage of asymptomatic (ASB) and symptomatic (CAUTI) bacteriuria
Tidsramme: 30 days
|
To study the incidence and progression of asymptomatic bacteriuria and CAUTI in patients with prolonged foley catheters for greater than 72 hours.
|
30 days
|
Time to Bacteriuria (ASB and CAUTI)
Tidsramme: 30 days
|
To study the progression of asymptomatic bacteriuria and CAUTI in patients with prolonged foley catheters for greater than 72 hours.
|
30 days
|
Urine Culture Comparisons
Tidsramme: 30 days
|
To study the correlation between patient urine cultures and cultures taken from the Foley (Foley tip, urine sampled from collection bag).
|
30 days
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Kevin Foster, MD, Maricopa Integrated Health System (MIHS)
Studierekorddatoer
Studer hoveddatoer
Studiestart (Forventet)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CRD-06-100548
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Brannsår
-
Central Arkansas Veterans Healthcare SystemUnited States Department of Defense; University of ArkansasRekrutteringÅpne Burn Pit ExposureForente stater
-
Cairo UniversityFullført
-
Cairo UniversityRekruttering
-
Nepal Health Research CouncilFogarty International Center of the National Institute of HealthRekruttering
-
Seoul National University HospitalMind Works Clinical Psychologist GroupHar ikke rekruttert ennå
-
Chinese University of Hong KongCity University of Hong KongFullførtStress (psykologi) | Burn Out (psykologi)Hong Kong
-
University of North Carolina, Chapel HillFullført
-
Maasstad HospitalRed Cross Hospital Beverwijk; Association of Dutch Burn Centres; Martini...RekrutteringBrannsår | Blodtap | Blodtap, kirurgisk | Tranexamsyre | Burn excisional kirurgiNederland
-
Arrowhead Regional Medical CenterFullførtBrannsår | Mangel på askorbinsyre | Væske og elektrolytt ubalanse | Forbrenningsgrad andre | Forbrenningsgrad tredje | Burn ShockForente stater
-
University of WashingtonFogarty International Center of the National Institute of HealthFullført
Kliniske studier på Standard of Care
-
University of Alabama at BirminghamTilbaketrukketFysisk aktivitetForente stater
-
University of FloridaPatient-Centered Outcomes Research InstituteAktiv, ikke rekrutterendeProstatakreftForente stater
-
University of Colorado, DenverRekruttering
-
Vanderbilt UniversityFullført
-
University of Maryland, BaltimoreFullført
-
NRG OncologyNational Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; Eastern Cooperative Oncology Group og andre samarbeidspartnereRekrutteringHER2-positiv brystkreftForente stater, Puerto Rico
-
Stryker EndoscopyRekrutteringSkulderskader | Kneskader | HofteskaderForente stater
-
University of OklahomaRekruttering
-
Adera Labs, LLCMemorial Sloan Kettering Cancer Center; Weill Medical College of Cornell... og andre samarbeidspartnerePåmelding etter invitasjonNeoplasmer i bukspyttkjertelenForente stater